Alerts will be sent to your verified email
Verify Email
FDC
|
FDC
|
Strides Pharma Scien
|
Unichem Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
5.7 % | n/a | n/a |
|
R&D as a % of Total Sales
|
2.06 % | 1.82 % | 7.38 % |
|
Financials
|
|||
|
5 yr Average ROE
|
13.66 % | -4.18 % | -2.21 % |
|
5yr average Equity Multiplier
|
1.57 | 2.64 | 1.28 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 0.54 | 0.42 |
|
5yr Avg Net Profit Margin
|
16.24 % | -2.56 % | -3.85 % |
|
Price to Book
|
2.77 | 2.38 | 1.88 |
|
P/E
|
23.15 | 20.04 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-14.0 Days | -66.38 Days | 80.33 Days |
|
Inventory Days
|
59.23 Days | 69.16 Days | 146.44 Days |
|
Days Receivable
|
21.91 Days | 71.28 Days | 128.35 Days |
|
Days Payable
|
86.54 Days | 248.23 Days | 225.53 Days |
|
5yr Average Interest Coverage Ratio
|
93.3 | 0.41 | -0.08 |
|
5yr Avg ROCE
|
14.95 % | 9.77 % | -0.47 % |
|
5yr Avg Operating Profit Margin
|
18.97 % | 13.1 % | 2.2 % |
|
5 yr average Debt to Equity
|
0.0 | 1.02 | 0.09 |
|
5yr CAGR Net Profit
|
4.94 % | n/a | 3.21 % |
|
5yr Average Return on Assets
|
8.73 % | -1.34 % | -1.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.66 % | 26.82 % | 70.22 % |
|
Share Pledged by Promoters
|
0.0 | 54.25 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.3 % | -2.78 % | 19.29 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.62 % | -3.98 % | 2.02 % |